Scripps research team reveals how an old drug could have a new use for treating river blindness
| 2/9/2010 | LA JOLLA, CA--Scientists at The Scripps Research Institute have discovered a potential new use for the drug closantel, currently the standard treatment for sheep and cattle infected with liver fluke. The new research suggests that the drug may be useful in combating river blindness, a tropical disease that is the world's second leading infectious cause of blindness for humans. The study i... [Comments] |
Modeling Toxoplasma focus of workshop
| 2/9/2010 | Toxoplasma gondii ( T. gondii ) is considered as one of the most successful parasites for its unusual ability to infect a wide range of intermediate hosts, including all mammals and birds. Up to 11% of the human population in the US and 20% in the world are chronically infected. The National Institute for Mathematical and Biological Synthesis (NIMBioS) is now accepting applications for... [Comments] |
New era of pain drugs advanced by Barrow researcher
| 2/9/2010 | Research led by a scientist at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has opened the door for the advancement of a new category of painkillers, called TRPV1 antagonists. These drugs block the transient receptor potential vannilloid-1 (TRPV1) channel, which is the same receptor responsible for the sensation of hotness from hot peppers. However, clinical tri... [Comments] |
Research identifies gene with likely role in premenstrual disorder
| 2/9/2010 | Scientists have identified a gene they say is a strong candidate for involvement in premenstrual dysphoric disorder (PMDD) and other maladies associated with the natural flux in hormones during the menstrual cycle. In a paper published Monday in the Proceedings of the National Academy of Sciences , Rockefeller University researchers detail experiments in mice showing that a common human varian... [Comments] |
'Revolutionary' water treatment units on their way to Afghanistan
| 2/9/2010 | HUNTSVILLE, TX- The United States Army has taken delivery of the first two units of a "revolutionary" waste-water treatment system that will clean putrid water within 24 hours and leave no toxic by-products, according to scientists at Sam Houston State University. "The system is based on a proprietary consortium of bacteria- you can find them in a common handful of dirt," said lead scientist... [Comments] |
Pacific Biomarkers, Inc. Schedules Second Quarter Conference Call for Friday, February 12, 2010
| 2/9/2010 | SEATTLE , Feb. 9 Pacific Biomarkers, Inc. (OTC Bulletin Board: PBME), which provides specialty reference biomarker services to support pharmaceutical and laboratory diagnostic manufacturers in the conduct of human clinical research, today announced that it has scheduled an investor conference call for 11:15 a.m. EST ( 8:15 a.m. PST ) on Friday, F... [Comments] |
Researchers reveal 3-D structure of bullet-shaped virus with potential to fight cancer, HIV
| 2/9/2010 | Vesicular stomatitis virus, or VSV, has long been a model system for studying and understanding the life cycle of negative-strand RNA viruses, which include viruses that cause influenza, measles and rabies. More importantly, research has shown that VSV has the potential to be genetically modified to serve as an anti-cancer agent, exercising high selectivity in killing cancer cells while... [Comments] |
UC Riverside licenses technology to OlFactor Laboratories, Inc.
| 2/9/2010 | RIVERSIDE, Calif. -- OlFactor Laboratories, Inc., a majority owned subsidiary of Avisio, Inc. acquired an exclusive license to patented technology from UC Riverside. The technology is based on an advanced scientific understanding of how two-winged blood-feeding insects, e.g. mosquitos a... [Comments] | ![]() |
Mouse Anti-Snail, a.a. 150-39 Antibody, Unconjugated from CHEMICON
Description:Snail, a.a. 150-39...Rat Anti-Mouse IgM Heavy Chain Monoclonal Antibody, Unconjugated, Clone LO-MM-3 from Cell Sciences
Description:Anti-Mouse IgM Heavy Chain, Clone LO-MM-3, Monoclonal Antibody...Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:HOXC11 Antibody...Rabbit Anti-BAFF-R (CT) BR3 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:BAFF-R (CT) BR3 Affinity Purified Polyclonal Antibody...Chicken Anti-HOXC11 Polyclonal Antibody, Unconjugated from ProSci, Inc
Description:HOXC11 Antibody...| 2/9/2010 | NEW YORK , Feb. 9 Reportlinker.com announces that a new market research report is available in its catalogue: The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) http://www.reportlinker.com/p0176223/The-Clinical-Laboratory-Services-Market-Growth-Opportunities-Competitive... [Comments] |
Reportlinker Adds SNP Genotyping and Analysis Markets
| 2/9/2010 | NEW YORK , Feb. 9 Reportlinker.com announces that a new market research report is available in its catalogue: SNP Genotyping and Analysis Markets http://www.reportlinker.com/p0176225/SNP-Genotyping-and-Analysis-Markets.html Because SNPs (single nucleotide polymorphisms),are the most common type of genetic variation betw... [Comments] |
endpoint Saves Money and Time for Medical Research Teams Through PULSE
| 2/9/2010 | SAN FRANCISCO , Feb. 9 endpoint Clinical ( www.endpointclinical.com ), a leader in Integrated Voice Response (IVR)/Integrated Web Response (IWR) systems, announced today that PULSE, a fully configurable platform that allows users to design and deploy clinical trial Integrated Response Technology (IRT) systems, saves 40 percent on the development time of c... [Comments] |
Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors
| 2/9/2010 | SAN DIEGO , Feb. 9 Ardea Biosciences, Inc. (Nasdaq: RDEA ) today announced that Felix J. Baker , Ph.D., has been appointed to the Company's Board of Directors. Dr. Baker is a managing partner of Baker Bros. Advisors, LLC, the manager and advisor to the funds of Baker Brothers Investments, Ardea's largest shareholder. "Ardea's impr... [Comments] |
| 2/9/2010 | CHENGDU, China , Feb. 9 /PRNewswire-Asia-FirstCall/ -- TianyinPharmaceutical Co., Inc., (NYSE Amex: TPI ), a manufacturer and supplier ofmodernized traditional Chinese medicine ("TCM") and Western Pharmaceuticalsbased in Chengdu, China , today announced that it expects operational benefitsfrom the recently published Guide to Reform of Pricing Mechanism... [Comments] |